CLL-Current and Emerging Therapies
Please join us for our upcoming telephone/web education program, CLL- Current and Emerging Therapies on, Wednesday, June 18, 2014 1:00-2:30 pm EST featuring Thomas Kipps, MD, Deputy Director for Research at the University of California Moores Cancer Center.
Thomas Kipps, MD
Please join us for our upcoming telephone/web education program,
CLL- Current and Emerging Therapies
on, Wednesday, June 18, 2014 1:00-2:30 pm EST featuring Thomas Kipps, MD, Deputy Director for Research at the University of California Moores Cancer Center.
Topics will include:
- The goal of CLL treatment
- How staging influences personalized treatment planning
- Current treatment options for CLL
- Emerging therapies and clinical trials for CLL
- Side effects management
- The importance of open communication with your treatment team
For more information, please contact the Leukemia & Lymphoma’s Information Resource Center at 800-955-4572 or
.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.
